Home » Topics » BioWorld Science

BioWorld Science
RSS

IDMC recommends continuation of phase III study of masitinib for metastatic CRPC

June 20, 2018

Argenx reports cohort 1 interim data from phase II study of efgartigimod in pemphigus vulgaris

June 20, 2018

Clinical benefit noted with NIR-178 in patients with non-small cell lung cancer

June 20, 2018

Tumor mutations can aid variant calling for germline

June 20, 2018

Idorsia initiates phase III study of aprocitentan for resistant hypertension

June 20, 2018

Kala updates registration plan for KPI-121 for short-term treatment of dry eye disease

June 20, 2018

Can-Fite updates status of phase II trial of namodenoson in advanced HCC

June 20, 2018

Seattle Children's initiates phase I trial of CAR T-cell therapy for pediatric CNS tumors

June 20, 2018

Monalizumab shows promising activity in combination with durvalumab in MSS-CRC

June 20, 2018

Andes-1537 well tolerated in phase I study, dose expansions planned

June 20, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...